# USPSTF 2021: screening for hypertension in adults

Guideline · id `cardio:guideline-uspstf-2021-hypertension-screening` · Cardiovascular Atlas · release `73130c34862e2d06` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement

Browse, organ or system: Blood vessels  
Browse, condition area: Risk and prevention; High blood pressure  

## In plain language

The 2021 reaffirmation by the United States Preventive Services Task Force of its advice to screen adults aged 18 or older for high blood pressure with an office measurement, and to confirm a diagnosis with measurements taken outside the clinic before starting treatment. It carries the Task Force's highest grade, A.

## Technical summary

JAMA 2021;325(16):1650-1656, doi 10.1001/jama.2021.4987, PMID 33904861. The USPSTF page dates the final statement April 27, 2021. Only the PubMed abstract and that date line were read. The abstract says the Task Force used a reaffirmation process for its 2015 recommendation. The USPSTF permits reuse of its work only under its copyright notice, so this atlas states the recommendation in its own words, with a citation and a link.

## Claims, with the population each applies to

## Context: Adults 18 or older without known hypertension (USPSTF 2021 reaffirmation)

Recipient: Adult; Population: People from age 18 with no known hypertension, as the abstract defines the population.; Care setting: Not stated in the abstract. The recommendation concerns screening with a reading taken in the office and confirmation with readings taken outside the clinical setting.; Geography: United States (a USPSTF recommendation; the abstract gives US figures); Life stage: Adults aged 18 or older; Follow-up: Not applicable (guideline context)

### The USPSTF advises screening adults aged 18 or older for hypertension with an office blood pressure reading, and advises taking measurements outside the clinical setting to confirm the diagnosis before treatment starts (grade A). It reaffirmed its 2015 recommendation and, using a reaffirmation process, concluded with high certainty that screening has a substantial net benefit.

- Category: Recommendation
- Evidence stage: Guidance
- Certainty: Certainty not assessed
- Applies to: Recipient: Adult; Population: People from age 18 with no known hypertension, as the abstract defines the population.; Care setting: Not stated in the abstract. The recommendation concerns screening with a reading taken in the office and confirmation with readings taken outside the clinical setting.; Geography: United States (a USPSTF recommendation; the abstract gives US figures); Life stage: Adults aged 18 or older; Follow-up: Not applicable (guideline context)
- Limitations: A reaffirmation of the 2015 recommendation, reached through what the abstract calls a reaffirmation deliberation process. The abstract names no screening interval and no method for out-of-office measurement; those details were not read. The A label is read from the parenthesis that follows the last recommendation sentence in the abstract. The Task Force certainty is its own rating, not GRADE. Only the PubMed abstract and the date line of the USPSTF page were read. No recommendation record is written, because this atlas has no record for blood pressure screening itself.
- Last checked: 2026-10-15
- Sources:
  1. Supports: Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement (Guideline, edition Reaffirmation statement published in JAMA 2021;325(16):1650-1656. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement.) <https://doi.org/10.1001/jama.2021.4987>
     Locator: Abstract, RECOMMENDATION, sentence 1. Retrieved 2026-10-15T13:48:56Z. Source state: Current. Snapshot hash: 768b951661f84879b6c87abd3f08bb13a68299f4f53074bd7b4e84b618c835cb.
     How it applies: Screening of adults from age 18, using an office reading.
  2. Supports: Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement (Guideline, edition Reaffirmation statement published in JAMA 2021;325(16):1650-1656. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement.) <https://doi.org/10.1001/jama.2021.4987>
     Locator: Abstract, RECOMMENDATION, sentence 2. Retrieved 2026-10-15T13:48:56Z. Source state: Current. Snapshot hash: 768b951661f84879b6c87abd3f08bb13a68299f4f53074bd7b4e84b618c835cb.
     How it applies: Confirm with measurements outside the clinic before treatment.
  3. Supports: Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement (Guideline, edition Reaffirmation statement published in JAMA 2021;325(16):1650-1656. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement.) <https://doi.org/10.1001/jama.2021.4987>
     Locator: Abstract, RECOMMENDATION, sentence 3. Retrieved 2026-10-15T13:48:56Z. Source state: Current. Snapshot hash: 768b951661f84879b6c87abd3f08bb13a68299f4f53074bd7b4e84b618c835cb.
     How it applies: The grade A label.
  4. Supports: Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement (Guideline, edition Reaffirmation statement published in JAMA 2021;325(16):1650-1656. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement.) <https://doi.org/10.1001/jama.2021.4987>
     Locator: Abstract, EVIDENCE ASSESSMENT, sentence 1. Retrieved 2026-10-15T13:48:56Z. Source state: Current. Snapshot hash: 768b951661f84879b6c87abd3f08bb13a68299f4f53074bd7b4e84b618c835cb.
     How it applies: High certainty of substantial net benefit, by the reaffirmation process.
  5. Supports: Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement (Guideline, edition Reaffirmation statement published in JAMA 2021;325(16):1650-1656. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement.) <https://doi.org/10.1001/jama.2021.4987>
     Locator: Abstract, OBJECTIVE, sentence 1, fragment 1 of 3. Retrieved 2026-10-15T13:48:56Z. Source state: Current. Snapshot hash: 768b951661f84879b6c87abd3f08bb13a68299f4f53074bd7b4e84b618c835cb.
     How it applies: Reaffirms the 2015 recommendation.
  6. Background: Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement (Guideline, edition Reaffirmation statement published in JAMA 2021;325(16):1650-1656. PubMed abstract and bibliographic data, plus the date line of the USPSTF recommendation page (both fetched 2026-10-15). The full statement and the evidence review were not read. PubMed lists no correction to the statement.) <https://doi.org/10.1001/jama.2021.4987>
     Locator: Page header, date line of the final recommendation statement. Retrieved 2026-10-15T13:55:02Z. Source state: Current. Snapshot hash: 1bd19fe30db0b99409d9d054092987dba733b5626971845da2f83431a7919886.
     How it applies: Date of the final statement.

## Connected pages

- Issuer: the Task Force is named as the author in the PubMed record: U.S. Preventive Services Task Force (`core:uspstf`)

## Provenance

Content hash: db93f1c6a71fcff4b9a38a2be95b6e2b77d5d4ca87abb2cfe7aa12d5961dd183
Last substantive edit: 2026-10-15
Evidence last checked: 2026-10-15